Articles dans des revues avec comité de lecture (55)
34.
Lamoral-Theys, D., Wauthoz, N., Heffeter, P., Mathieu, V., Jungwirth, U., Lefranc, F., Neve, J., Dubois, J., Dufrasne, F., Amighi, K., Berger, W., Gailly, P., & Kiss, R. (2012). Trivanillic polyphenols with anticancer cytostatic effects through the targeting of multiple kinases and intracellular Ca 2+ release. Journal of Cellular and Molecular Medicine, 16(7), 1421-1434. doi:10.1111/j.1582-4934.2011.01403.x.37.
Ionescu, A., Dufrasne, F., Gelbcke, M., Jabin, I., Kiss, R., & Lamoral-Theys, D. (2012). DYRK1A Kinase Inhibitors with Emphasis on Cancer. Mini-reviews in medical chemistry, 12(13), 1315-1329.38.
Le Calve, B., Lallemand, B., Perrone, C., Lenglet, G., Depauw, S., Van Goietsenoven, G., Bury, M., Vurro, M., Herphelin, F., Andolfi, A., Zonno, M. C., Mathieu, V., Dufrasne, F., Van Antwerpen, P., Poumay, Y., David-Cordonnier, M.-H., Evidente, A., & Kiss, R. (2011). In vitro anticancer activity, toxicity and structure-activity relationships of phyllostictine A, a natural oxazatricycloalkenone produced by the fungus Phyllosticta cirsii. Toxicology and applied pharmacology, 254(1), 8-17. doi:10.1016/j.taap.2011.03.02739.
Dufrasne, F., Gelbcke, M., Neve, J., Kiss, R., & Kraus, J.-L. (2011). Quinone methides and their prodrugs: a subtle equilibrium between cancer promotion, prevention, and cure. Current medicinal chemistry, 18(26), 3995-4011. doi:10.2174/09298671179695730140.
Soubhye, J., Prévost, M., Van Antwerpen, P., Zouaoui Boudjeltia, K., Rousseau, A., Furtmüller, P. G., Obinger, C., Vanhaeverbeek, M., Ducobu, J., Neve, J., Gelbcke, M., & Dufrasne, F. (2010). Structure-based design, synthesis, and pharmacological evaluation of 3-(Aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors. Journal of medicinal chemistry, 53(24), 8747-8759. doi:10.1021/jm100998841.
Berger, G., Gasper, R., Lamoral-Theys, D., Wellner, A., Gelbcke, M., Gust, R., Neve, J., Kiss, R., Goormaghtigh, E., & Dufrasne, F. (2010). Fourier transform infrared (FTIR) spectroscopy to monitor the cellular impact of newly synthesized platinum derivatives. International journal of oncology, 37(3), 679-686. doi:10.3892/ijo-0000071742.
Lamoral-Theys, D., Pottier, L., Kerff, F., Dufrasne, F., Proutiere, F., Wauthoz, N., Neven, P., Ingrassia, L., Van Antwerpen, P., Lefranc, F., Gelbcke, M., Pirotte, B., Kraus, J.-L., Neve, J., Kornienko, A., Kiss, R., & Dubois, J. (2010). Simple di- and trivanillates exhibit cytostatic properties toward cancer cells resistant to pro-apoptotic stimuli. Bioorganic & medicinal chemistry, 18(11), 3823-3833. doi:10.1016/j.bmc.2010.04.04743.
Lamoral-Theys, D., Pottier, L., Dufrasne, F., Neve, J., Dubois, J., Kornienko, A., Kiss, R., & Ingrassia, L. (2010). Natural polyphenols that display anticancer properties through inhibition of kinase activity. Current medicinal chemistry, 17(9), 812-825. doi:10.2174/09298671079071218344.
Van Antwerpen, P., Moreau, P., Zouaoui Boudjeltia, K., Babar, S., Dufrasne, F., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., & Neve, J. (2008). Development and validation of a screening procedure for the assessment of inhibition using a recombinant enzyme. Talanta, 75(2), 503-510. doi:10.1016/j.talanta.2007.11.04045.
Van Antwerpen, P., Prévost, M., Zouaoui Boudjeltia, K., Babar, S., Legssyer, I., Moreau, P., Moguilevsky, N., Vanhaeverbeek, M., Ducobu, J., Neve, J., & Dufrasne, F. (2008). Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification. Bioorganic & medicinal chemistry, 16(4), 1702-1720. doi:10.1016/j.bmc.2007.11.025